This study investigates the treatment of moderate-to-severe atopic dermatitis (AD) in participants aged 12 years and older. The purpose is to evaluate the effects of a subcutaneous treatment for those who have not responded well to previous biologic therapies or oral JAK inhibitors.The study will focus on assessing the safety …
This study investigates the effect of an investigational medication, an Anti-OX40L Monoclonal Antibody, in adults with moderate to severe atopic dermatitis. The study will compare the investigational medication to other treatment arms to assess its effectiveness.Participants will be randomly assigned to one of five study arms in a double-blind manner, …
This study investigates atopic dermatitis with the aim to explore the unmet needs in treating this condition and to understand the patient journey when starting or switching systemic treatments.The focus of the study is to evaluate the safety and outcomes of systemic treatments for atopic dermatitis in real-world settings. It …
This study investigates the effects of atopic dermatitis (AD) on pregnancy outcomes. This observational study will compare the incidence of adverse pregnancy outcomes, such as miscarriage or stillbirth, and the prevalence of adverse infant outcomes, like major congenital malformations or being small for gestational age, in women with AD who …
